-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on Bio-Rad Laboratories, Raises Price Target to $330

Benzinga·08/05/2026 18:54:46
Listen to the news
Citigroup analyst Daniel Grosslight maintains Bio-Rad Laboratories (NYSE:BIO) with a Neutral and raises the price target from $300 to $330.